Pages

Thursday, April 24, 2014

FDA Advisors Reject Combination Pain Pill Moxduo

The FDA's Anesthetic and Analgesic Products Advisory Committee has voted unanimously to reject Moxduo , an investigational pain pill that combines two common opioids, oxycodone hydrochloride and morphine sulfate.

http://ift.tt/1jSMxSD

No comments:

Post a Comment